Conclusion: Our findings uncover a previously unrecognized mechanism mediated by differential TME and CD147+ EV macropinocytosis in HCC and highlight the LPA-Arf6-macropinocytosis as a novel targeting axis to overcome SFR in HCC. Here, ARF6 is linked to hepatocellular carcinoma.